Clinical trial
Fasudil Eye Drop in Retinopathy Of Prematurity, Retinal Vascularization Induction and Disease Progression Inhibition, a Randomized Clinical Trial
NCT04191954 is registered in ClinicalTrials.gov with Shahid Beheshti University of Medical Sciences as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Fasudil Eye Drop in Retinopathy Of Prematurity, Retinal Vascularization Induction and Disease Progression Inhibition, a Randomized Clinical Trial
- Lead sponsor
- Shahid Beheshti University of Medical Sciences
- Phase
- Phase 2/3
- Overall status
- Unknown status
- Start date
- June 2, 2019
- Completion date
- September 30, 2020
- Enrollment
- 184 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.